COVID-19 Updates: Learn more| Flu Shot Available!

What Is Monoclonal Antibody Therapy?

Monoclonal antibodies are developed in a lab and function similarly to your body’s inherent naturally occurring antibodies. Monoclonal antibodies are administered intravenously to high-risk COVID-19 patients diagnosed with the early stages of the disease. Generally, the infusion decreases risk of progression of COVID-19 from mild and moderate disease to severe disease by a 3-4X relative risk reduction.

How Does Monoclonal Antibody Treatment Work Against COVID-19?

This treatment is generally used to decrease viral loads and reduce symptom severity in high-risk COVID-19 patients. Monoclonal antibodies can detect and target the spike protein found on the outer part of the COVID-19 virus. This reduces the virus’s ability to attach itself and enter human cells. Generally, it has been proven to boost our immune system and help it fight off the novel coronavirus. It also helps decrease the risk of being hospitalized.

Who Is Eligible for Monoclonal Antibody Treatment?

You are eligible for this treatment if you have experienced symptoms of COVID-19 (mild to moderate) in the last ten days or less, have tested positive for COVID-19, and have any of the following high-risk factors:

  • You are 65 or older
  • Or you belong to the age group 12 to 64 and suffer from any of the following medical conditions:
    • Overweight or obese (BMI > 25) or if you are in the age group 12-17 (BMI greater than 85th percentile)
    • Chronic Kidney Disease
    • Pregnancy
    • Diabetes
    • Any immunosuppressive treatment or disease
    • Cardiovascular disease (congenital condition included)
    • Hypertension
    • Chronic lung disease (e.g., moderate asthma, COPD, interstitial lung disease, and cystic fibrosis)
    • Neurodevelopmental disorders (e.g., cerebral palsy)
    • Sickle cell disease
    • Dependent on medical technologies such as gastrostomy, tracheostomy, and positive pressure ventilation

Please Note: All appointments need to be scheduled at least 24 hours in advance and are subject to availability with any test results performed at any other facility requiring evidence of a positive PCR test. Walk-ins will not be accepted for this time.

CLICK HERE TO APPLY FOR A TELEMEDICINE APPOINTMENT TO CONFIRM YOUR ELIGIBILITY.

Book MAB Appointment!

FAQs

Per CDC, if you have been treated with a monoclonal antibody infusion, you should not get a COVID-19 vaccination within 90 days of your infusion.

No – reach out to us immediately. This therapy works best when given early, usually within ten days of you testing positive for COVID-19.

Side effects are rare but may include infusion reactions such as nausea, vomiting, diarrhea, fever, headache, chills, wheezing or coughing, decreased blood pressure, skin swelling, rashes, throat irritation, muscle pain/ache, itching, weakness, and dizziness. Inform your doctor immediately if you feel any of these symptoms after the infusion.

Whether or not you have received monoclonal antibody therapy, you need to be isolated if you have tested positive for COVID-19.

Please check with your insurance provider to see if you can receive the infusion at no cost to you.

Call Us